Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 187 transactions and raising C$19.5 Billion on behalf of our clients in Q3/20211.2.

Filter our transactions* using the categories below:

Clear all filters
Clear all filters
Yellow Cake plc
US$140m
February 2021

Yellow Cake plc

Nomad and Joint Bookrunner (Fundraise)
METALS AND MINING EQUITY CAPITAL MARKETS CORPORATE BROKING JERSEY
View transaction detail
TheScore
US$186m
February 2021

TheScore

Joint Bookrunner (US IPO)
TECHNOLOGY EQUITY CAPITAL MARKETS CANADA
Dropbox, Inc.
US$1b
February 2021

Dropbox, Inc.

Co-Manager (144a Convert)
TECHNOLOGY EQUITY CAPITAL MARKETS US
Velocity Acquisition Corp.
US$230m
February 2021

Velocity Acquisition Corp.

Joint Bookrunner (IPO)
SPACS EQUITY CAPITAL MARKETS US
MicroStrategy Incorporated
US$1b
February 2021

MicroStrategy Incorporated

Co-Manager (144a Convert)
TECHNOLOGY EQUITY CAPITAL MARKETS US
Travere Therapeutics Inc.
US$175m
February 2021

Travere Therapeutics Inc.

Lead Manager (Follow-on)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Kaledio
US$69m
February 2021

Kaledio

Lead Manager (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Jet2.com
£422m
February 2021

Jet2.com

Joint Global Coordinator, Joint Bookrunner and Joint Broker (Placing and Retail Offer)
INDUSTRIALS/AEROSPACE & DEFENSE AEROSPACE & DEFENCE CORPORATE BROKING EQUITY CAPITAL MARKETS UK
Bioventus Inc.
US$120m
February 2021

Bioventus Inc.

Lead Manager (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS US
Viant Technology, Inc.
US$288m
February 2021

Viant Technology, Inc.

Co-Manager (IPO)
TECHNOLOGY EQUITY CAPITAL MARKETS US
The ExOne Company
US$101m
February 2021

The ExOne Company

Joint Bookrunner (CMPO)
SUSTAINABILITY INDUSTRIALS/AEROSPACE & DEFENSE EQUITY CAPITAL MARKETS US
Rhythm Pharmaceuticals, Inc.
US$173m
February 2021

Rhythm Pharmaceuticals, Inc.

Lead Manager (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail

Here to support you...

  1. Company information as at 31 March 2019
  2. Transactions valued above C$1.5 million

* Transactions displayed here include transactions of Canaccord Genuity and its predecessors. The logos used in the tombstones represent Canaccord Genuity’s clients unless otherwise specified in the transaction description